6.71 USD
↗ 0.06 (0.83%)LIVE (AS OF 09:36 AM EDT)
Gyre Therapeutics, Inc. Common Stock
GYRENASDAQ • USD
Market: OPEN
Shares of Gyre Therapeutics, Inc. Common Stock (GYRE) are trading at $6.71. Technicals currently rate "Neutral" while our fundamental analysis reads "Sell". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, GYRE trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Aug 26, 2026.
Open?$6.65
High?$6.71
Low?$6.65
Prev. Close?$6.65
Volume?465
Avg. Volume?53.4K
VWAP?$6.67
Rel. Volume?0.01x
Bid / Ask
Bid?$6.60 × 200
Ask?$6.66 × 100
Spread?$0.06
Midpoint?$6.63
Valuation & Ratios
Market Cap?705.1M
Shares Out?111.5M
Float?17.8M
Float %?18.4%
P/E Ratio?N/A
P/B Ratio?6.53
EPS?-$0.17
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.
Employees
618
Market Cap
705.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-10-31
Address
12730 HIGH BLUFF DRIVE
SAN DIEGO, CA 92130
Phone: (858) 284-0115
SAN DIEGO, CA 92130
Phone: (858) 284-0115
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?8
Short Sent.?48
Piotroski F-Score?0/9Weak
Altman Z-Score?12.24Safe
Confidence?51%Low
Short InterestVery High
Short % of Float?9.78%Elevated
Short Interest?1.7M
Days to Cover?31.1
Free Float17.8M
Avg Daily Volume56.2K
Settlement Date2026-08-14
Financial Health
Current Ratio?4.26Strong
Quick Ratio?3.86Strong
Cash Ratio?1.51Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score75/100
P/E?N/A▾
P/B?6.53FAIR▾
Peers100
S&P28
P/S?5.91FAIR▾
Peers100
S&P23
P/FCF?N/A▾
EV/EBITDA?-50.2CHEAP▾
S&P97
EV/Sales?5.54FAIR▾
Peers100
S&P32
Returns & Efficiency
ROE?-17.1%WEAK▾
S&P8
ROA?-9.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-15749000
Enterprise Value?$661.8M
Fundamentals ratios updated end of day